Novel fused heterocyclic derivatives useful as c-Met tyrosine kinase inhibitors
摘要
<p>Certain novel fused quinazoline derivatives of formula (I) as c-Met inhibitors, their synthesis and their uses for treating a c-Met mediated disorder. Methods for treating a c-Met-mediated disorder are also disclosed in the invention.</p>
